A new variant of the novel coronavirus called EG.5 is spreading in Japan, with experts expecting it to be the dominant strain ...

Vaccines are one of the most powerful tools in modern medicine. They help protect people from serious diseases by training the body’s immune system to recognize and fight infections. Over the years, ...

As Pfizer gears up to defend its patents on transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis in court this week, eleventh-hour settlements with two of the three generic drugmakers involved ...

Pfizer’s chief strategist, Andrew Baum, M.D., is leaving his post two years after pivoting from a career-long tenure as a biopharma equity research analyst to join the New York drugmaker. Baum is ...

Pfizer (PFE) executive Andrew Baum, hired in 2024 as its Chief Strategy and Innovation Officer to overhaul the company’s strategic direction, is leaving the drugmaker later this year, according to a ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

April 28 (Reuters) - Pfizer (PFE.N), opens new tab said on Tuesday it has settled ‌patent disputes with three generic drugmakers over its blockbuster heart drug Vyndamax, effectively extending its ...

Pfizer is facing patent cliffs on multiple drugs in the next few years. The company has been making big acquisitions to strengthen its growth prospects. The stock trades at an incredibly low valuation ...

There's actually nothing unusual going on with Pfizer's pharmaceutical business. The industry is highly competitive, capital-intensive, and driven by innovation. Unfortunately, research and ...

The company releases its Q1 earnings on May 5th, in less than 2 weeks, so I think it's time for me to update my reasoning and take a look at what's coming next for PFE. First off, let me briefly ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) will present new data across its diverse, industry-leading Oncology pipeline and portfolio at the American Society of Clinical Oncology (ASCO) Annual ...

Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...